Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Amyotrophic lateral sclerosis/Parkinsonism-dementia complex in Kii peninsula, Japan (Kii ALS/PDC), is an endemic neurodegenerative disease whose causes and pathogenesis remain unknown. However, astrocytes in autopsied cases of Kii ALS/PDC show characteristic lesions. In addition, relationships between extracellular vesicles (EVs) and neurodegenerative diseases are increasingly apparent. Therefore, we focused on proteins in EVs derived from Kii ALS/PDC astrocytes in the present study.
Methods: Induced pluripotent stem cells (iPSCs) derived from three healthy controls (HCs) and three patients with Kii ALS/PDC were differentiated into astrocytes. EVs in the culture medium of astrocytes were collected and subjected to quantitative proteome analysis.
Results: Our proteome analysis reveals that EV-containing proteins derived from astrocytes of patients with Kii ALS/PDC show distinctive patterns compared with those of HCs. Moreover, EVs derived from Kii ALS/PDC astrocytes display increased proteins related to proteostasis and decreased proteins related to anti-inflammation.
Discussion: Proteins contained in EVs from astrocytes unveil protective support to neurons and may reflect the molecular pathomechanism of Kii ALS/PDC; accordingly, they may be potential biomarker candidates of Kii ALS/PDC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10072-023-07000-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
C9orf72 repeat expansions in Wakayama: One potential cause of amyotrophic lateral sclerosis in the Kii Peninsula, Japan.
J Neurol Sci
November 2024
Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
A cluster of cases of amyotrophic lateral sclerosis (ALS) exists in the southern part of the Kii Peninsula in Japan. Although both genetic and environmental factors are thought to be causative, the critical cause of this cluster has not been identified. C9orf72 is the most common genetic factor in both familial and sporadic C9orf72-related ALS in people of European ancestry, but it is rare among Japanese populations.
View Article and Find Full Text PDFAberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes.
Acta Neuropathol
May 2024
Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC), a rare and complex neurological disorder, is predominantly observed in the Western Pacific islands, including regions of Japan, Guam, and Papua. This enigmatic condition continues to capture medical attention due to affected patients displaying symptoms that parallel those seen in either classical amyotrophic lateral sclerosis (ALS) or Parkinson's disease (PD). Distinctly, postmortem examinations of the brains of affected individuals have shown the presence of α-synuclein aggregates and TDP-43, which are hallmarks of PD and classical ALS, respectively.
View Article and Find Full Text PDFReply to: Questioning the cycad theory of Kii ALS-PDC causation.
Nat Rev Neurol
March 2024
Department of Neurology and Clinical Neuroscience Center, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
Questioning the cycad theory of Kii ALS-PDC causation.
Nat Rev Neurol
March 2024
Institute for Medical Science of Aging, Aichi Medical University, Nagakute City, Japan.
SPTLC2 variants are associated with early-onset ALS and FTD due to aberrant sphingolipid synthesis.
Ann Clin Transl Neurol
April 2024
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Article Synopsis
- The study focused on understanding the genetic basis of early-onset ALS, a severe neurodegenerative disease, by analyzing families with members diagnosed before the age of 40.
- Research methods included whole-exome sequencing and biochemical assessments, leading to the identification of gene variants in SPTLC2 that are linked to elevated sphingolipid production in early-onset ALS patients.
- Findings suggest a connection between specific genetic mutations and disrupted sphingolipid metabolism, contributing to ALS development and highlighting the genetic complexity of the disease.